Skip to main content
letter
. 2020 Nov 27;57(1):106245. doi: 10.1016/j.ijantimicag.2020.106245

Table 1.

Carbapenemase-producing Enterobacterales (CPE) in COVID-19 and non-COVID-19 patients (6 March–2 May 2020) in the general ICU (non-COVID-19) and in the COVID-19-devoted ICUs.

ICU type Blood cultures
Rectal swabs
No. of patients tested/total no. of patients in the ward (%) Blood culture/colonisation rate (%)
Pos. Neg. % CPE-pos. Pos. Neg. % CPE-pos.
Non-COVID-19 7a 29 19.4% 11b 28 28.2% 39/48 (81.3%) 7/11 (63.6%)
COVID-19 2c 23 8.0% 14d 27 34.1% 65/80 (81.3%) 2/14 (14.3%)

COVID-19, coronavirus disease 2019; ICU, intensive care unit.

a–dNumber of isolates per bacterial species and carbapenemase type:

a

7 Klebsiella pneumoniae KPC-positive

b

11 K. pneumoniae KPC-positive

c

1 K. pneumoniae KPC-positive and 1 K. pneumoniae OXA-48-positive.

d

4 K. pneumoniae KPC-positive and 10 K. pneumoniae OXA-48-positive.